共 37 条
- [1] Reaven, Role of insulin resistance in human disease, Diabetes, 37, pp. 1595-1607, (1988)
- [2] Defronzo, Ferrannini, Insulin resistance: a multifaceted syndrome responsible for NIDDM obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease, Diabetes Care, 14, pp. 173-194, (1991)
- [3] Fuller, Epidemiology of hypertension associated with diabetes mellitus, Hypertension, 7, (1985)
- [4] Pollare, Lithell, Berne, A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension, N Engl J Med, 321, pp. 868-873, (1989)
- [5] Bllomgarden, Ginsberg-Fellner, Rayfield, Bookman, Brown, Elevated hemoglobin Alc and low density lipoprotein cholesterol levels in thiazidetreated diabetic patients, The American Journal of Medicine, 77, pp. 823-827, (1984)
- [6] Nguyen, Er tiazider diabetogene, Tidsskr-Nor-Laegeforen, 113, pp. 2587-2589, (1993)
- [7] Prince, Stuart, Padia, Et al., Metabolic effects of hydrochlorothiazide and enalapril during treatment of the hypertensive diabetic patient, Arch Intern Med, 148, pp. 2363-2368, (1988)
- [8] Ferriere, Lachkar, Richard, Et al., Captopril and insulin sensitivity, Ann Intern Med, 102, pp. 134-135, (1985)
- [9] McMurray, Fraser, Captopril, enalapril and blood glucose, Lancet, 1, (1986)
- [10] Alkharouf, Nalinikumari, Corry, Tuck, Long-term effects of the angiotensin convering enzyme inhibitor captopril on metabolic control in non-insulin-dependent diabetes mellitus, Am J Hypertens, 6, pp. 337-343, (1993)